232 related articles for article (PubMed ID: 7556378)
1. Angiotensin II receptor subtypes and contractile responses in portal vein smooth muscle.
Pelet C; Mironneau C; Rakotoarisoa L; Neuilly G
Eur J Pharmacol; 1995 Jun; 279(1):15-24. PubMed ID: 7556378
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
Feuillan PP; Millan MA; Aguilera G
Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor subtypes in cultured rat renal mesangial cells.
Ernsberger P; Zhou J; Damon TH; Douglas JG
Am J Physiol; 1992 Sep; 263(3 Pt 2):F411-6. PubMed ID: 1415569
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
Briand V; Riva L; Galzin AM
Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
[TBL] [Abstract][Full Text] [Related]
6. Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain.
Chrétien L; Guillemette G; Regoli D
Eur J Pharmacol; 1994 Apr; 256(1):73-8. PubMed ID: 7517891
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein.
Zhang JS; Van Meel JC; Pfaffendorf M; Van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):220-4. PubMed ID: 8474539
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin receptor subtypes in the uterine artery during ovine pregnancy.
Burrell JH; Lumbers ER
Eur J Pharmacol; 1997 Jul; 330(2-3):257-67. PubMed ID: 9253961
[TBL] [Abstract][Full Text] [Related]
10. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
11. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptors in the rat urinary bladder smooth muscle: type 1 subtype receptors mediate contractile responses.
Tanabe N; Ueno A; Tsujimoto G
J Urol; 1993 Sep; 150(3):1056-9. PubMed ID: 8345584
[TBL] [Abstract][Full Text] [Related]
13. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
Scott AL; Chang RS; Lotti VJ; Siegl PK
J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
[TBL] [Abstract][Full Text] [Related]
14. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonists.
van Meel JC; Entzeroth M; Hauel N; Narr B; Ries U; Wienen W
Arzneimittelforschung; 1993 Feb; 43(2A):242-6. PubMed ID: 8498971
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
Balla T; Baukal AJ; Eng S; Catt KJ
Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
[TBL] [Abstract][Full Text] [Related]
19. Novel angiotensin receptor subtypes in fowl.
Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
[TBL] [Abstract][Full Text] [Related]
20. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor.
Pucell AG; Hodges JC; Sen I; Bumpus FM; Husain A
Endocrinology; 1991 Apr; 128(4):1947-59. PubMed ID: 1848506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
